Quantcast

Company News For Feb 26, 2019


Shutterstock photo

  • Danaher Corp.'s DHR shares soared 8.5% after the company agreed to acquire biopharma business of General Electric Co. GE for $21.4 billion in cash
  • Shares of Spark Therapeutics Inc. ONCE jumped 120.1% after the company entered into a definite agreement merger agreement with Roche Holding AG for $4.8 billion in cash
  • Clementia Pharmaceuticals Inc. CMTA shares surged 74.7% after France's Ipsen agreed to acquire Canada-based group house in a deal valued at up to $1.31 billion
  • Shares of Carter's Inc. CRI climbed 8.4% after posting fourth quarter 2018 adjusted earnings per share of $2.84, surpassing the Zacks Consensus Estimate of $2.57

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

General Electric Company (GE): Free Stock Analysis Report

Danaher Corporation (DHR): Free Stock Analysis Report

Spark Therapeutics, Inc. (ONCE): Free Stock Analysis Report

Carter's, Inc. (CRI): Free Stock Analysis Report

Clementia Pharmaceuticals Inc. (CMTA): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.





This article appears in: Investing , Business , Investing Ideas , Stocks
Referenced Symbols: GE , DHR , ONCE , CRI ,




More from Zacks.com

Subscribe






Zacks.com
Contributor:

Zacks.com

Equity Research












Research Brokers before you trade

Want to trade FX?